STAAR Surgical Reports Second Quarter 2026 Results
STAAR Surgical reported a strong financial turnaround for the second quarter of 2026, with net sales rising 111% year-over-year to $93.5 million and net income reaching $8.1 million compared to a prior-year loss. The performance was driven by a recovery in China, where sales grew over 100% sequentially and 189% year-over-year, alongside double-digit growth in the Americas and a 74.5% gross margin.
Key figures
- Eps
- 0.16
- Revenue
- 93500000
- Revenue Yoy
- 111%
- China sales
- 52300000
- Gross margin
- 74.5%
- Adjusted ebitda
- 20000000
- Operating income
- 10100000
- Cash and investments
- 181500000
- Adjusted ebitda per share
- 0.39
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.